Table 5 Comparison of the different variables in patients submitted to radical gastrectomy about the presence of micrometastases in gastric carcinoma (n = 51).

From: Impact of multisection and immunohistochemistry in lymph node staging of Gastric Carcinoma – Case series

Variables

Micrometastases

p-valor

No n(%)

Yes n (%)

Gender

  

0.264

Female

12 (42.9)

14(60.9)

 

Male

16 (57.1)

9 (39.1)

 

Age (years)

  

1.000

Mean ± standard deviation

62.8 ± 15.0

62,7 ± 14.8

 

Gastrectomy

  

0.577

Subtotal

15 (53.6)

10 (43.5)

 

Total

13 (46.4)

13 (56.5)

 

Tumor size (cm)

  

0.239

Mean ± standard deviation

4.3 ± 2.6

5.0 ± 2.2

 

Stomach site

  

0.769

Body/Proximal

9 (32.1)

9 (39.1)

 

Distal

19 (67.9)

14 (60.9)

 

Serous tumor depth

  

0.141

No

21 (75.0)

12 (52.2)

 

Yes

7 (25.0)

11 (47.8)

 

Laurén

  

0.225

Diffuse

11 (39.3)

10 (43.5)

 

Intestinal

13 (46.4)

6 (26.1)

 

Mixed

4 (14.3)

7 (30.4)

 

Vascular/Lymphatic/Neural invasion

   

Vascular

9 (32.1)

15 (65.2)

0.026

Lymphatic

12 (42.9)

20 (87.0)

0.001

Neural

7 (25.0)

11 (47.8)

0.141

  1. p-test significant when <0.05.
  2. It was shown that 60% of the advanced gastric cancer patients had micrometastases compared to 12,5% of the early gastric cancer group (p = 0,002).